Transforming Allergy Treatment

About us

Management Profiles

Ignace GoethalsKeith CarterIan PostlethwaiteTom HoldichChristian GrätzStephen SmithVirinder NohriaKevin WilkinsonRay Keeling
Click on a thumbnail image or on one of the links below to view a biography for that individual.

Profile Details

Ignace Goethals  

Ignace Goethals

Non-Executive Chairman (63)

Ignace has had a successful career in the pharmaceutical industry, with Eli Lilly, Squibb/Bristol Myers Squibb and SmithKline Beecham rising to the highest levels prior to retiring at the end of 1998 when he was head of world-wide supply operations.

His experience is exceptionally broad, covering sales and marketing, country and regional general management positions, licensing and business development, business unit management (Biologicals and Animal Health) and supply.

Ignace has a degree in Applied Economics from the University of Louvain (Belgium) and an MBA from the University of Chicago.

As Non-Executive Chairman, Ignace is responsible for leadership of the Board by ensuring Board effectiveness, good corporate governance and effective communication with shareholders.

Ignace sits on the Audit and Remuneration committees. 


AT Management

AT Senior Management Team and Board of Directors have wide commercial and technical experience in pharmaceutical product and business development, finance and R&D.

The Company is managed on a day-to-day, as well as strategic basis, through the Executive Management Committee.

In the UK, the operations are primarily manufacturing and product development, as well as certain market support functions. In continental Europe the Company has sales and marketing operations in Germany, Italy and Spain. The three most important European markets for allergy vaccination.

AT employs a total of 350 staff, included in these figures are over 66 sales representatives on the road supported by 60 office-based staff in the European markets.